Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Discontinued Operations (Tables)

v3.10.0.1
Note 3 - Discontinued Operations (Tables)
6 Months Ended
Jun. 30, 2018
Notes Tables  
Disposal Groups, Including Discontinued Operations [Table Text Block]
   
June 30
,
2018
   
December 31,
2017
 
Accrued liabilities
  $
    $
7,092
 
Liabilities associated with discontinued operations, current
  $
    $
7,092
 
   
Three Months Ended
June
30,
   
Six
Months Ended
June
30,
 
   
2018
   
2017
   
2018
   
2017
 
Lymphoseek sales revenue
  $
    $
9,663
    $
    $
2,926,876
 
Cost of goods sold
   
     
24,216
     
     
388,408
 
Gross profit
   
     
(14,553
)
   
     
2,538,468
 
Operating expenses:
                               
Research and development
   
2,453
     
75,196
     
2,453
     
358,729
 
Selling, general and administrative
   
     
     
     
820,203
 
Total operating expenses
   
2,453
     
75,196
     
2,453
     
1,178,932
 
(Loss) income from discontinued operations
   
(2,453
)
   
(89,749
)
   
(2,453
)
   
1,359,536
 
Interest expense
   
     
     
     
(1,718,506
)
Loss before income taxes
   
(2,453
)
   
(89,749
)
   
(2,453
)
   
(358,970
)
Benefit from income taxes
   
515
     
7,373
     
515
     
20,733
 
Loss from discontinued operations
  $
(1,938
)
  $
(82,376
)
  $
(1,938
)
  $
(338,237
)